Rein Therapeutics, Inc. Debt Securities, Available-for-sale, Amortized Cost
Rein Therapeutics, Inc. (RNTX) had Debt Securities, Available-for-sale, Amortized Cost of $35.10 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-14
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $35.10M.
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost $501.00K.
- 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost $8.95M.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost $16.10M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $35.10M 10-Q · filed 2026-08-14 |
| 2023-06-30 | $501.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $8.95M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $16.10M 10-Q · filed 2023-10-13 |
| 2022-09-30 | $20.74M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $24.86M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $30.70M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $42.35M 10-K · filed 2023-03-20 |
| 2021-09-30 | $44.63M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $48.73M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $44.07M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.76M 10-K · filed 2022-03-28 |
| 2020-09-30 | $6.27M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.76M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $12.96M 10-K · filed 2021-03-24 |
| 2019-09-30 | $17.68M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $21.34M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $10.06M 10-K · filed 2020-03-30 |
| 2018-09-30 | $20.23M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $23.82M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $36.56M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $38.92M 10-K · filed 2019-03-29 |
| 2017-09-30 | $43.44M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.95M 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |